CD&R, Merck GHI and McKesson Ventures Recapitalize M2GEN

Veracyte to Acquire C2i Genomics to Add Whole-Genome MRD Capabilities

January 8, 2024

Healthcare Services

Veracyte has reached a definitive agreement to acquire C2i Genomics, a minimal residual disease (MRD) detection company, to add whole-genome MRD capabilities to its diagnostics platform. Under the terms, Veracyte will pay $70 million in Veracyte shares at closing and up to an additional $25 million tied to future performance milestones, expected to close in the first quarter of 2024.

CD&R Acquires Multi-Color Corporation and Fort Dearborn to Create Global Label Solutions Leader

November 1, 2021

Packaging

Clayton, Dubilier & Rice (CD&R) agreed to acquire Multi-Color Corporation (MCC) from Platinum Equity and Fort Dearborn Company from Advent International and combine the two businesses into a single global label solutions platform. The combined company will serve consumer packaged goods customers across Food & Beverage, Home & Personal Care, Wine & Spirits and other specialty end markets, creating roughly $3 billion in annual revenue and expanded global scale.

CD&R Acquires Majority Stake in Humana's Kindred at Home Hospice and Personal Care Divisions (Gentiva)

April 21, 2022

Healthcare Services

Clayton, Dubilier & Rice (CD&R) agreed to acquire a 60% interest in the Hospice and Personal Care divisions of Humana’s Kindred at Home, receiving approximately $2.8 billion in cash and valuing the divisions at about $3.4 billion. The carved‑out businesses were restructured into a standalone company rebranded as Gentiva, with Humana retaining a 40% minority stake and David Causby continuing as CEO; the deal closed in 2022 and remains subject to customary approvals noted at signing.

Clayton, Dubilier & Rice Partners with Vera Whole Health

July 1, 2021

Healthcare Services

Clayton, Dubilier & Rice (CD&R) has entered into an investment partnership with Vera Whole Health to support Vera's expansion of its value-based, primary care-focused model. Terms were not disclosed; existing minority investors Transformation Capital and Archimedes Health Investors will remain as minority stakeholders while CD&R will support growth and board leadership changes.

Clayton, Dubilier & Rice Acquires Huntsworth plc

May 1, 2020

Healthcare Services

Clayton, Dubilier & Rice (CD&R) agreed a recommended cash offer and completed the take-private acquisition of Huntsworth plc for approximately £575 million. CD&R said it will invest in Huntsworth’s healthcare-focused commercialization services—including medical affairs, market access and marketing—to support organic and acquisition-led growth under private ownership.

Clayton, Dubilier & Rice Acquires Majority Stake in Sirius Computer Solutions

July 1, 2019

IT Services

Clayton, Dubilier & Rice (CD&R) acquired a majority equity interest in Sirius Computer Solutions from funds affiliated with Kelso & Company. The partnership positions CD&R to support Sirius’ continued growth and expand its managed services, cloud, security and solutions offerings while Joe Mertens remains CEO.